The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter (in USD). This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.

Seventeen companies currently qualify for inclusion, with six filing in U.S dollars and eleven in the Canadian currency. Earlier this week, Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF), which is based in Canada but operates in the U.S. and reports in U.S. dollars, posted sales of $4.03 million for the quarter ending 12/31/17, representing growth of 79% from a year ago.

Both of the updates in Canada are for companies qualifying for the first time. Organigram (TSXV: OGI) (OTC: OGRMF) reported sales of C$3.22 million, representing growth of 122% from a year ago. Note that the sales in both periods exclude the impact of returns related to the recall issue. Sunniva (CSE: SNN) (OTC: SNNVF), which derives its revenue from its clinic and from ancillary sales, posted revenue of C$5.86 million.

In May, several companies will be providing quarterly updates, including Aurora Cannabis (TSX: ACB) (OTC: ACBFF), CannTrust (TSX: TRST) (OTC: CNTTF) and Sunniva in Canada and CV Sciences (OTC: CVSI),  GrowGeneration (OTC: GRWG), GW Pharma (NASDAQ: GWPH) and Terra Tech (OTC: TRTC) in the United States.

Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email